Japan start-up Innophys Co. is expanding overseas in nations that have aging populations to offer its wearable exoskeleton to support heavy lifting.
Set up by Tokyo University of Science professor Hiroshi Kobayashi, Innophys Co, hopes its products will be used in the care and farm fields in Europe, China, and South Korea, where similar age-related social issues occue.
Innophys Executive Officer Masaru Yoda said that with demand for assistive suits getting greater as populations age, they have a chance at being top in the world.
The firm has a domestic market share of about 70 percent. It sold around 20,000 Muscle Suit in April 2021 since launching it in 2014.
The exoskeletons support the arms and back.
They employ artificial muscles that are composed of rubber tubes covered in nylon mesh that expand when compressed air is added, creating a strong pulling force that can help with physically demanding manual activities and lessen back strain when lifting large goods.
The suit, which is worn like a backpack, can greatly reduce stress when performing heavy factory work, caregiving, and agricultural duties. It is also a useful tool for averting potential workplace mishaps.
Each item costs about 150,000 yen and weighs about 4 kg.
In 2020, Innophys began to expand into Taiwan, Hong Kong, and Macao. Currently, the company has sales representatives in 17 nations and areas, including China, South Korea, Germany, and France.


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 



